HomeFATE • NASDAQ
Fate Therapeutics Inc
add
$1.01
5.21%
After Hours:(4.06%)-0.041
$0.97
Closed: May 15, 7:21:45 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.63M | -15.38% |
Operating expense | 42.91M | 105.75% |
Net income | -37.62M | 21.63% |
Net profit margin | -2.31K | 7.39% |
Earnings per share | -0.32 | 31.91% |
EBITDA | -37.95M | 17.95% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 240.43M | -37.31% |
Total assets | 398.67M | -30.04% |
Total liabilities | 110.26M | -23.31% |
Total equity | 288.41M | — |
Shares outstanding | 114.63M | — |
Price to book | 0.38 | — |
Return on assets | -24.59% | — |
Return on capital | -26.61% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -37.62M | 21.63% |
Cash from operations | -33.81M | -1.38% |
Cash from investing | 42.67M | 146.47% |
Cash from financing | — | — |
Net change in cash | 8.86M | -88.84% |
Free cash flow | -28.11M | -508.53% |
Previous close
$0.96
Day range
$0.93 - $1.04
Year range
$0.66 - $5.91
Market cap
115.78M USD
Avg Volume
2.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2007
Website
Employees
181
